Early stage life sciences company iBIONICS has had “a phenomenal year of growth and learning,” says CEO and co-founder Suzanne Grant.
The company, which is developing a bionic-eye system to restore vision in people with retinal degenerative diseases, has reached combined private and public funding goals of US$2.5 million and added another $1.5 million in grants; it also expects to finalize additional pre-seed financing in the next two quarters.
The firm has secured an exclusive worldwide licence for its prototype and has recently celebrated several other business and technical milestones.
OBJ360 (Sponsored)
Navigating innovation often means stepping off the beaten path to ensure success, especially when it comes to intellectual property in tech. That’s why Swidget decided to partner with the IP
A Canadian surgical first at The Ottawa Hospital using VR technology
The Ottawa Hospital’s discoveries never end! They found a new way to take patient care into the future, today using VR technology.
Ms. Grant and iBIONICS were also chosen to exhibit at the Accessibility Innovation Showcase at the Invictus Games in Toronto in September.